Edwin A. Basak

Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients

Edwin A. Basak, Jan W.M. van der Meer, Daan P. Hurkmans et al. · Thyroid · 2020 · 88 citations

Life Sciences, Immunology, Oncology +17

A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients

Daan P. Hurkmans, Edwin A. Basak, Tanja C. van Dijk et al. · Journal for ImmunoTherapy of Cancer · 2019 · 82 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Correlation between nivolumab exposure and treatment outcomes in non–small-cell lung cancer

Edwin A. Basak, Stijn L.W. Koolen, Daan P. Hurkmans et al. · European Journal of Cancer · 2019 · 72 citations

Pharmacy, Oncology, Pharmacotherapy +13

Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer

Daan P. Hurkmans, Edwin A. Basak, Nina Schepers et al. · Journal for ImmunoTherapy of Cancer · 2020 · 72 citations · Full text

Life Sciences, Immunology, Oncology +17

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients

Sander Bins, Edwin A. Basak, Samira El Bouazzaoui et al. · British Journal of Cancer · 2018 · 67 citations · Full text

Medicine, Immunology, Oncology +17